XRONIK KUNDALIK BOSH OG‘RIQLARINI SHAXSIYLASHTIRILGAN DAVOLASH: GENETIK VA QON TOMIR MARKERLARINING AHAMIYATI
;
Shaxsiylashtirilgan terapiya, xronik bosh og‘riq, genetik markerlar, tomir markerlari, individual davolash, klinik prognoz, hayot sifati.Abstrak
Ushbu maqolada xronik kundalik bosh og‘riqlarni (XKBO) davolashda shaxsiylashtirilgan yondashuvning ahamiyati yoritilgan. Asosiy e’tibor kasallik patogenezida genetik va tomir markerlarining ta’siriga hamda davolash samaradorligiga qaratilgan. Genetik omillar bosh og‘riqlarining individual xususiyatlarini belgilashda va organizmning dori vositalariga javobini prognoz qilishda muhim rol o‘ynaydi. Tomir markerlari esa miyada qon aylanishi va trofika o‘zgarishlarini baholash imkonini beradi. Ilmiy tahlil natijalari shuni ko‘rsatadiki, shaxsiylashtirilgan terapiyadan foydalanish davolash samaradorligini oshirishi, nojo‘ya ta’sirlarni kamaytirishi va bemorning hayot sifatini yaxshilashi mumkin.
Iqtiboslar
Diener HC, Solbach K, Holle D, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12(10):575-583.
Jiménez-Sánchez L, et al. Role of homocysteine in migraine: pathways, genes and pharmacogenetics. Pharmacol Res. 2021;167:105576.
Kowa H, et al. The influence of MTHFR gene polymorphism on the efficacy of triptans in migraine attacks. Neurology. 2012;78(7):544-547.
Ke X, et al. The link between hyperhomocysteinemia and vascular cognitive impairment: A meta-analysis. Neurosci Biobehav Rev. 2021;126:146-158.
Bockowski L, Sobaniec W, Kulak W. Plasma homocysteine and B vitamins in children with migraine. Headache. 2005;45(4):346-352.
